Latest Breaking News On - Us medical affairs - Page 10 : comparemela.com

New ERLEADA® (apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new real-world evidence data showing the initiation of ERLEADA®.

United statesSan franciscoBenjamin lowentrittTracy mcgowanPaloma felicianoJanssen biotech incNational comprehensive cancer network incAmerican urological associationJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonLaboratory abnormalitiesProstate cancer panelJanssen scientific affairsUs medical affairsNone of the janssen pharmaceutical companies

Medical education through Twitter? Pharma s digital strategy for healthcare providers

“Most Q&As are happening on Twitter. If you’re not doing social listening you’re losing fresh insights into things like disease states." That was just one of the observations in a new report on how pharma and other life science companies are working with healthcare providers and adapting to improve the patient experience.

Luca dezzaniAlex bedenkovUs medical affairsReuters eventsVice presidentWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock healthStartup adviceStartup fundingPatient monitoring system

Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial

Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial
asnjournals.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asnjournals.org Daily Mail and Mail on Sunday newspapers.

Eteläuomen läiBaden wübergUnited statesUnited kingdomLaura johnstoneVifor pharmaAstra zenecaDaiichi sankyoEli lillyBirdrock bioBoehringer ingelheim lillyRelypsa vifor pharmaUs veterans administrationReata pharmaceuticalsBoehringer ingelheimIronwood pharmaceuticals

Corbus Pharmaceuticals Appoints Rachael Brake, Ph D , as Chief Scientific Officer

Corbus Pharmaceuticals Appoints Rachael Brake, Ph D , as Chief Scientific Officer
ycharts.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ycharts.com Daily Mail and Mail on Sunday newspapers.

Western australiaUnited statesLindsey smithAlan holmerYuval cohenCorporate communications patient advocacyUniversity of western australia perthCorbus pharmaceuticals holdings incMillennium pharmaceuticals incResearch at amgen incExchange commissionTakeda pharmaceuticalsSecurities exchangeCorbus pharmaceuticals contactPrnewswire corbus pharmaceuticals holdings incUs medical affairs

Arcturus Therapeutics Appoints Jing Marantz, M D , Ph D , M B A to its Board of Directors

Arcturus Therapeutics Appoints Jing Marantz, M D , Ph D , M B A to its Board of Directors
news8000.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news8000.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoJing marantzCarlo tanziJingl marantzJoseph payneDeepankar royKrystal biotech incGlobal medical affairsJanssen pharmaceuticals incCystic fibrosis foundationJanssen pharmaceutical companies of johnsonTakeda pharmaceutical companyMerck co incHead of medical affairs at alnylam pharmaceuticalsUs medical affairs